(R)-2-(((Benzyloxy)carbonyl)amino)-3-fluoropropanoic acid, 95.0%, 250mg

(3-Chloro-4-ethoxyphenyl)boronic acid, 95.0%, 25g

5-Bromo-7-fluoro-benzofuran-2-carboxylic acid, 1g

(butan-2-yl)[(3,4-dichlorophenyl)methyl]amine, 95.0%, 10g

Nepsilon-(2,4-Dinitrophenyl)-L-lysine Hydrochloride>98.0%(HPLC)100mg

2,4,7,9-Tetramethyl-5-decyne-4,7-diol (DL- and meso- mixture)>95.0%(GC)25g

5-ETHYNYL-2-HYDROXYBENZALDEHYDE, 95.0%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 3.00 µm, 1 Piece(s)

Valeric anhydride; >95%, 98.0%, 25ml

Pt- cis-Dichlorodiamine platinum(II) 5 g

(propan-2-yl)({[4-(trifluoromethyl)phenyl]methyl})amine hydrochloride, 95.0%, 10g

3-Fluoro-2-[(piperidin-4-yl)methoxy]pyridine dihydrochloride, 1g

cis-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutane-1-carbonitrile, 95.0%, 250mg